Mujumdar Prashant, Bua Silvia, Supuran Claudiu T, Peat Thomas S, Poulsen Sally-Ann
Griffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, Brisbane, Queensland 4111, Australia.
NEUROFARBA Dept., Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
Bioorg Med Chem Lett. 2018 Sep 15;28(17):3009-3013. doi: 10.1016/j.bmcl.2018.04.038. Epub 2018 Apr 16.
Here we report the synthesis of natural products (NPs) 5'-O-sulfamoyl adenosine 1 and 5'-O-sulfamoyl-2-chloroadenosine 2. As primary sulfamates these compounds represent an uncommon class of NPs, furthermore there are few NPs known that contain a NS bond. Compounds 1 and 2 were evaluated for inhibition of carbonic anhydrases (CA), a metalloenzyme family where the primary sulfamate is known to coordinate to the active site zinc and form key hydrogen bonds with adjacent CA active site residues. Both NPs were good to moderate CA inhibitors, with compound 2 a 20-50-fold stronger CA inhibitor (K values 65-234 nM) than compound 1. The protein X-ray crystal structures of 1 and 2 in complex with CA II show that it is not the halogen-hydrophobic interactions that give compound 2 a greater binding energy but a slight movement in orientation of the ribose ring that allows better hydrogen bonds to CA residues. Compounds 1 and 2 were further investigated for antimicrobial activity against a panel of microbes relevant to human health, including Gram-negative bacteria (4 strains), Gram-positive bacteria (1 strain) and yeast (2 strains). Antimicrobial activity and selectivity was observed. The minimum inhibitory concentration (MIC) of NP 1 was 10 µM against Gram-positive Staphylococcus aureus and NP 2 was 5 µM against Gram-negative Escherichia coli. This is the first time that NP primary sulfamates have been assessed for inhibition and binding to CAs, with systematic antimicrobial activity studies also reported.
在此,我们报告天然产物(NPs)5'-O-氨磺酰腺苷1和5'-O-氨磺酰-2-氯腺苷2的合成。作为伯氨基磺酸酯,这些化合物代表了一类不常见的天然产物,此外,已知含N-S键的天然产物很少。对化合物1和2进行了碳酸酐酶(CA)抑制活性评估,碳酸酐酶是一类金属酶家族,已知伯氨基磺酸酯可与活性位点的锌配位,并与相邻的CA活性位点残基形成关键氢键。这两种天然产物都是良好至中等强度的CA抑制剂,化合物2作为CA抑制剂的活性(K值为65 - 234 nM)比化合物1强20 - 50倍。化合物1和2与CA II复合物的蛋白质X射线晶体结构表明,并非卤素-疏水相互作用赋予化合物2更大的结合能,而是核糖环方向的轻微移动使得与CA残基形成了更好的氢键。进一步研究了化合物1和2对一组与人类健康相关的微生物的抗菌活性,包括革兰氏阴性菌(4株)、革兰氏阳性菌(1株)和酵母(2株)。观察到了抗菌活性和选择性。NP 1对革兰氏阳性金黄色葡萄球菌的最低抑菌浓度(MIC)为10 μM,NP 2对革兰氏阴性大肠杆菌的最低抑菌浓度为5 μM。这是首次评估天然产物伯氨基磺酸酯对CA的抑制和结合作用,并报告了系统的抗菌活性研究。